Skip to Main Content

Acquired Von Willebrand Disease

Acquired Von Willebrand Disease

Condition Basics

What is acquired von Willebrand disease?

Acquired von Willebrand disease is a rare bleeding disorder that might be caused by other medical problems or medicines. It prevents blood from clotting properly. It is rarer than the inherited form of von Willebrand disease.

What causes it?

Medical problems that might cause acquired von Willebrand disease include:

Rarely, acquired von Willebrand disease may also develop in direct association with use of certain medicines. When use is discontinued, signs of the disease also end. These medicines include:

  • Ciprofloxacin.
  • Griseofulvin.
  • Valproic acid.

What are the symptoms?

Symptoms include nosebleeds with no previous history of bleeding abnormalities.

How is acquired von Willebrand disease treated?

Treatment of acquired von Willebrand disease includes medicines that help your body have enough von Willebrand clotting factor in the blood. This von Willebrand factor helps your blood clot.

Related Information

Credits

Current as of: December 13, 2023

Author: Ignite Healthwise, LLC Staff
Clinical Review Board
All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

Current as of: December 13, 2023

Author: Ignite Healthwise, LLC Staff

Clinical Review Board
All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

This information does not replace the advice of a doctor. Ignite Healthwise, LLC, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.

© 2024 Ignite Healthwise, LLC.

This information does not replace the advice of a doctor. Ignite Healthwise, LLC, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.